Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118046 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118043 |
| APO-OXCARBAZEPINE | 600MG | TABLET | Resolved | 2020-06-10 | 2022-02-09 | 117395 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-06-16 | 2023-07-13 | 195086 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-27 | 183474 |
| APO-OXYBUTYNIN | 1MG | SYRUP | Actual shortage | 2017-08-13 | 2017-10-05 | 19045 |
| APO-OXYBUTYNIN | 5MG | TABLET | Actual shortage | 2025-03-07 | 2025-03-07 | 252151 |
| APO-OXYBUTYNIN | 5MG | TABLET | Actual shortage | 2025-10-10 | 2025-10-10 | 269341 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187229 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2022-12-23 | 2023-01-26 | 179456 |
| APO-OXYBUTYNIN - TAB 5MG | 5MG | TABLET | Resolved | 2017-04-07 | 2018-11-30 | 5865 |
| APO-OXYBUTYNIN - TAB 5MG | 5MG | TABLET | Resolved | 2017-06-28 | 2018-11-30 | 14201 |
| APO-OXYBUTYNIN - TAB 5MG | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
| APO-OXYCODONE CR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-02-08 | 69921 |
| APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-09-22 | 17263 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-05-24 | 423 |
| APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-12 | 196312 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-24 | 2022-03-21 | 151889 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-10-11 | 2018-03-13 | 25304 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-05 | 8615 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |